GSK PLC-SPON ADR (GSK)       28.66  -0.16 (-0.56%)

7 Stocks to Buy That Can Soar in Good Times or in Bad

Investors looking for growth stocks to buy that are largely immune from broader economic woes have come to the right place.

Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement

Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK).

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

3 Biotech Stocks to Buy Now for Extraordinary Gains

These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.

Is Sanofi A Buy, Despite Recent Stumbles?

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.

Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug

Shares extended deep losses following a Zantac-inspired downturn last week.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm